This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Jefferies analyst Roger Song initiated coverage on Wave Life Sciences Ltd. WVE with a Buy rating and announced a price target of $26. WAVE Life Sciences shares closed at $10.48 on Monday. See how other analysts view this stock.
• TD Securities analyst Andrew Charles initiated coverage on Kura Sushi USA, Inc. KRUS with a Hold rating and announced a price target of $72. Kura Sushi USA shares closed at $64.71 on Monday. See how other analysts view this stock.
• Leerink Partners analyst Joseph Schwartz initiated coverage on Maze Therapeutics, Inc. MAZE with an Outperform rating and announced a price target of $28. Maze Therapeutics shares closed at $10.82 on Monday. See how other analysts view this stock.
• RBC Capital analyst Leonid Timashev initiated coverage on Insmed Incorporated INSM with an Outperform rating and announced a price target of $100. Insmed shares closed at $80.03 on Monday. See how other analysts view this stock.
• Keybanc analyst Tim Rezvan initiated coverage on Infinity Natural Resources, Inc. INR with an Overweight rating and announced a price target of $26. Infinity shares closed at $19.13 on Monday. See how other analysts view this stock.

Considering buying INSM stock? Here’s what analysts think:

Read This Next:

• How To Earn $500 A Month From Lowe’s Stock Ahead Of Q4 Earnings